Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_assertion type Assertion NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_head.
- NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_assertion wasGeneratedBy ECO_0000203 NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_provenance.
- NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_assertion wasDerivedFrom befree-20140225 NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_provenance.
- NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_assertion SIO_000772 22950635 NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_provenance.
- NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_assertion evidence source_evidence_literature NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_provenance.
- NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_assertion description "[We previously demonstrated that 5-aza-2'-deoxycytidine (DAC) could significantly increase the susceptibility of renal cell carcinoma (RCC) cells to paclitaxel (PTX) treatment in vitro, and showed the synergy of DAC and PTX against RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425695.RA3zSmhh02eIrKn_kNRuKBjmvOxiQIJEHg7I90A120mwI130_provenance.